All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: China Resources Sanjiu Medical & Pharma, Sigma Healthcare and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • China Healthcare Weekly (Feb.2)- Update on CR Sanjiu’s Acquisition of Tasly, China Biotech’s Outlook
  • Quiddity Leaderboard ASX Mar 25: LONGs up ~10% Vs SHORTs in a Month; More to Come
  • (Mostly) Asia-Pac M&A: Sigma Healthcare Dropsuite, Japfa, Dada Nexus, Malaysia Airports, Sanyo Steel


China Healthcare Weekly (Feb.2)- Update on CR Sanjiu’s Acquisition of Tasly, China Biotech’s Outlook

By Xinyao (Criss) Wang

  • If product sales cannot continue to climb rapidly and dilute the costs, the final profit will gradually fade away. Therefore, Chinese biotech companies need new blockbuster products to drive growth.
  • The decline in the number of biotech companies in the future is actually “a supply side reform” that fundamentally reduces market competition, which obviously benefit those first-tier companies.
  • The acquisition of Tasly by China Resources Sanjiu Medical & Pharma is still in progress. The deal may not be completed until 25H1 if the approval time is not enough.

Quiddity Leaderboard ASX Mar 25: LONGs up ~10% Vs SHORTs in a Month; More to Come

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for ASX 300, 200, 100, 50, and 20 in the run-up to the March 2025 index rebal event.
  • We expect two changes for ASX 50, one change for ASX 100, and seven changes for ASX 200. Separately we see 8 ADDs and 6 DELs for ASX 300.
  • The Sigma Healthcare – Chemist Warehouse merger will be completed soon and there will be major inflows for Sigma Healthcare due to float percentage/share count upgrades.

(Mostly) Asia-Pac M&A: Sigma Healthcare Dropsuite, Japfa, Dada Nexus, Malaysia Airports, Sanyo Steel

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Samsung Fire & Marine Insurance and more

By | Daily Briefs, Financials

In today’s briefing:

  • Samsung Fire & Marine Insurance: Strong Corporate Value Up Plan


Samsung Fire & Marine Insurance: Strong Corporate Value Up Plan

By Douglas Kim

  • On 31 January, Samsung Fire & Marine Insurance (000810 KS) announced a comprehensive corporate value up plan.
  • The three major areas of focus include K-ICS ratio (220%), ROE targets of 11-13%, and total shareholder returns to 50% by 2028. 
  • The company plans to reduce the treasury shares as a percentage of total outstanding shares from 15.9% to 5% by 2028 (10.9% of total outstanding shares over over four years).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Contemporary Amperex Technology (CATL), Fast Retailing, Guotai Junan Securities , Japfa Comfeed Indonesia, Sigma Healthcare, Indian Renewable Energy Development Agency, Areit (AyalaLand REIT), Sanyo Special Steel, Chuoh Pack Industry, Giga Prize and more

By | Daily Briefs, Most Read

In today’s briefing:

  • CATL (300750 CH): Index Inclusion Post H-Share Listing
  • Fast Retailing (9983 JP): Double Capping & The Reverse Funding Trade
  • Guotai Junan/Haitong Sec Merger: The Many Index Flows Around the Corner
  • IDX30/​​LQ45/IDX80 Index Rebalance: Big Impact in Some Stocks with 4 Days to Implementation
  • Sigma Healthcare (SIG AU): Shareholders Approve Merger; Passives Could Start Buying in Two Weeks
  • Indian Renewable Energy (IREDA IN) QIP: Index Implications
  • PCOMP Index Rebalance: AREIT, CBC to Replace NIKL, WLCON
  • Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book
  • Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover
  • Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block


CATL (300750 CH): Index Inclusion Post H-Share Listing

By Brian Freitas


Fast Retailing (9983 JP): Double Capping & The Reverse Funding Trade

By Brian Freitas


Guotai Junan/Haitong Sec Merger: The Many Index Flows Around the Corner

By Brian Freitas


IDX30/​​LQ45/IDX80 Index Rebalance: Big Impact in Some Stocks with 4 Days to Implementation

By Brian Freitas


Sigma Healthcare (SIG AU): Shareholders Approve Merger; Passives Could Start Buying in Two Weeks

By Brian Freitas

  • Sigma Healthcare (SIG AU) and Chemist Warehouse (CWG) shareholders have approved the merger with 99.86% and 100% of the votes cast in favour.
  • The Second Court Hearing is on 3 February and the merger will be implemented on 12 February, which is when the passive buying could commence.
  • Sigma Healthcare has continued to trade higher on a record margin and sales expansion for CWG and expected passive buying that could top A$3bn over the next few months.

Indian Renewable Energy (IREDA IN) QIP: Index Implications

By Brian Freitas

  • IREDA has announced a Qualified Institutional Placement (QIP) of a maximum of INR 50bn as long as the Government of India’s holding does not drop by more than 7%.
  • There will be passive buying at the time of settlement of the QIP shares while the increase in float will bring the stock closer to inclusion in another global index.
  • With the stock close to index inclusion level and down 37% from its peak, there could be positioning in the stock for passive inflows.

PCOMP Index Rebalance: AREIT, CBC to Replace NIKL, WLCON

By Brian Freitas


Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book

By Travis Lundy

  • 6-7 years ago Sanyo Special Steel (5481 JP) bought out a large foreign specialty steel company, and funded it by getting Nippon Steel to inject capital at below book. 
  • Now Nippon Steel is buying the rest of Sanyo Special Steel in a Tender Offer at 0.66x book, where most of book is Net Receivables, Inventory, WIP, and Materials.
  • This is the second time in a decade where the Board has decided to sell control of itself at far below book value. They should be ashamed of themselves.

Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover

By Travis Lundy

  • Today, Nikkon Holdings (9072 JP) announced it would take over Chuoh Pack Industry (3952 JP) for ¥5,034/share. It closed today at ¥1,349. This is a HUGE win for governance.
  • The 273% premium is not the big win here. For holders it is, of course, but for Japan Inc shareholders everywhere, the win was the auction process. 
  • This could have come out at 100% premium and that might have been OK. As it is, cross-holders and one big holder together get this deal done. Congrats!

Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block

By Travis Lundy

  • Today, Freebit Co Ltd (3843 JP) announced it would launch a Tender Offer next Monday to buy out minorities in 60.9%-owned Giga Prize (3830 JP)
  • The multiple is not terribly impressive. It could be better. But they only need 5.8% of the 39.1% they do not own to get this over the hump.
  • Synergies are clear. They are expected. They are not priced in the valuation. This is disappointing. Again.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Consumer: Fast Retailing, Tesla and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Last Week in Event SPACE: Fast Retailing, Sigma, Takeda Pharmaceutical, WH Group
  • Tesla’s Growth Story Facing Challenges Amidst Optimism for AI and Autonomy?


Last Week in Event SPACE: Fast Retailing, Sigma, Takeda Pharmaceutical, WH Group

By David Blennerhassett

  • It was confirmed on Friday afternoon Fast Retailing (9983 JP) was a single cap move, NOT a double-capping in a single Review. That limits the sell down.
  • Chemist Warehouse’s reverse buyout of pharmacy wholesaler Sigma Healthcare (SIG AU) is now all-but complete.
  • Takeda Pharmaceutical (4502 JP) announced decent results, decently upgraded guidance in both IFRS/GAAP terms and in Core/Adjusted terms (less impressive uplift in Adjusted/Analysed terms). They also announced a ¥100bn buyback.

Tesla’s Growth Story Facing Challenges Amidst Optimism for AI and Autonomy?

By Baptista Research

  • Tesla’s fourth-quarter earnings highlighted a company at the crossroads of transformation and challenge.
  • Despite achieving a record market valuation of $1.5 trillion in December, the company’s core automotive business struggled, with an 8% year-over-year revenue decline.
  • Demand softened, particularly for the Cybertruck, forcing Tesla to rely on aggressive promotional strategies to sustain sales.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japan Strategy Weekly | A Buying Opportunity in the AI Rubble? and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Strategy Weekly | A Buying Opportunity in the AI Rubble?
  • AUCTUS ON FRIDAY – 31/01/2025


Japan Strategy Weekly | A Buying Opportunity in the AI Rubble?

By Mark Chadwick

  • The recent market tremors sparked by DeepSeek, a Chinese AI firm, have rattled investors, prompting a wave of selling in AI stocks
  • The long-term AI narrative remains compelling and the current dip could offer compelling opportunities – we highlight the sell-off in Japanese names
  • The Bank of Japan’s long-standing commitment to ultra-loose monetary policy is looking increasingly untenable

AUCTUS ON FRIDAY – 31/01/2025

By Auctus Advisors

  • AUCTUS PUBLICATIONS ________________________________________ Corcel (CRCL LN)C; Target price of 1.00p per share: Restarting intervention activities at Tobias field -Intervention activities will soon restart at the Tobias-13 and Tobias-14 wells on Block KON-11, aiming to re-establish production at the Tobias field.
  • Discovered in 1961, the Tobias field initially had an estimated 94 mmbbl of oil in place.
  • Twelve wells were drilled, with eight producers reaching peak production of 17.5 mbbl/d.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Metsera Inc (MTSR): GLP-1 Boom Comes to the IPO Market with Explosive Debut and more

By | Daily Briefs, ECM

In today’s briefing:

  • Metsera Inc (MTSR): GLP-1 Boom Comes to the IPO Market with Explosive Debut
  • Titan America (TTAM): Cement Producer IPO Spin-Off Poised for Growth Amid Favorable Industry Trends
  • Infinity Natural Resources (INR): Buyers Step In Marking Second Winning Energy IPO
  • Maze Therapeutics (MAZE): Upsized IPO Slumps in the Aftermarket


Metsera Inc (MTSR): GLP-1 Boom Comes to the IPO Market with Explosive Debut

By IPO Boutique

  • Metsera (MTSR US), a biotech using peptides to treat obesity, overweight and related conditions opened 41.7% above the issue price. 
  • The company was seeking a specific cash-raise of $275 million and was not looking to allow further dilution.
  • IPOs in the biotech sector are a “sell-the-news” event until we see on the tape otherwise.

Titan America (TTAM): Cement Producer IPO Spin-Off Poised for Growth Amid Favorable Industry Trends

By IPO Boutique

  • Spinoff of European Parent Titan Cement is seeking a potential $3b valuation.
  • The financial metrics of this company have been steadily improving which could lend a strong opportunity if priced attractively. 
  • We will be taking a wait-and-see approach for our short-term time frame forecast regarding this deal versus the issue price.

Infinity Natural Resources (INR): Buyers Step In Marking Second Winning Energy IPO

By IPO Boutique

  • Throughout the week, Infinity Natural Resources had to manage the Venture Global (VG) headwind — a previously broken IPO from the energy sector. 
  • While there was pushback on valuation with some buyside investors, Infinity Natural Resources was able to successfully convey their story.
  • There has now been three energy IPOs in 2025 with two winners.

Maze Therapeutics (MAZE): Upsized IPO Slumps in the Aftermarket

By IPO Boutique

  • Maze Therapeutics (MAZE US) upsized its transaction but saw its IPO price dip below issue on day one.
  • A critical piece of information, price guidance, was missing from the final channel check sending a warning message to the market.
  • With the lack of enthusiasm for this IPO during its first session, we would encourage investors to exercise caution on this IPO in the aftermarket.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Pemex: Lack of Concrete Action Weights on the Outperform Thesis and more

By | Credit, Daily Briefs

In today’s briefing:

  • Pemex: Lack of Concrete Action Weights on the Outperform Thesis
  • EM Spreads – Weekly News & Views


Pemex: Lack of Concrete Action Weights on the Outperform Thesis

By Leandro Gubler

  • We need to see concrete action from the Mexican government to maintain an Outperform recommendation.
  • Pemex’s deteriorating operational metrics will likely increase its need for government assistance.
  • Within Pemex’s capital structure, we continue to prefer the PEMEX (B3/BBB/B+) 5.950% 2031, the PEMEX 6.625% 2035, the PEMEX 6.625% 2038, and the PEMEX 7.690% 2050.

EM Spreads – Weekly News & Views

By Leandro Gubler

  • The LatAm Corporate Index tightened by 12 basis points (bps) to 306 bps in the week ending on Friday, January 31, 2025.
  • U.S. Treasuries saw decreases, with the 10-year yield down 11 bps to 4.51% and the 5-year yield also down 11 bps to 4.31%.
  • We initiated coverage on Suzano with a Market Perform outlook, Sheinbaum unveiled an energy reform, YPF completed its $327 million acquisition of Mobil, and Cemex finalized its $950 million divestment. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book
  • Daito Trust Buys Out Listed Private Co Ascot (3264 JP) – Small Done Deal at ¥260
  • Ascot Corp (3264 JP): Daito Trust Construction (1878 JP)’s Tender Offer a Done Deal
  • Sabadell’s Dividend Strategy and the BBVA Takeover Bid
  • EQD | NSE Nifty Bank Index – Implied Volatility Not (Yet) Rich Enough.
  • Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover
  • EQD | S&P/ASX 200 Option Strategy –  Today’s All-Time-High Calls for Proactive Hedging
  • EQD | Global Option Implied Volatility – Option Opportunities Across the Regions
  • Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block


Nippon Steal! Again. Parent Takes Out Sanyo Special Steel (5481) At Well Below Book

By Travis Lundy

  • 6-7 years ago Sanyo Special Steel (5481 JP) bought out a large foreign specialty steel company, and funded it by getting Nippon Steel to inject capital at below book. 
  • Now Nippon Steel is buying the rest of Sanyo Special Steel in a Tender Offer at 0.66x book, where most of book is Net Receivables, Inventory, WIP, and Materials.
  • This is the second time in a decade where the Board has decided to sell control of itself at far below book value. They should be ashamed of themselves.

Daito Trust Buys Out Listed Private Co Ascot (3264 JP) – Small Done Deal at ¥260

By Travis Lundy

  • Ping An Insurance bought into a small Tokyo-based condo developer in 2017 at ¥255/share. In 2020, it reinvested on the dip with SBI at ¥155/share.
  • Ping An and SBI started with zero shares. By 2020 they had 80+% of shares. Now they are selling out to Daito Trust Construct (1878 JP)
  • This is a done deal at a slight premium to book value. Daito Trust buys Real Estate Available for Sale and assumes debt. That’s it. Easy peasy done deal. 

Ascot Corp (3264 JP): Daito Trust Construction (1878 JP)’s Tender Offer a Done Deal

By Arun George

  • Ascot Corp (3264 JP) announced a tender offer from Daito Trust Construct (1878 JP) at JPY260 per share, a 20.4% premium to the last close.
  • Ascot currently does not meet the 25% tradeable share ratio criterion. The offer is attractive compared to historical trading ranges but below the mid-point of the IFA DCF valuation range.
  • This is a done deal, as irrevocables represent an 82.78% ownership ratio, well above the minimum acceptance condition (67.86% ownership ratio).  

Sabadell’s Dividend Strategy and the BBVA Takeover Bid

By Jesus Rodriguez Aguilar

  • Sabadell plans a €500 million share buyback to maintain stock value, reducing the attractiveness of BBVA’s exchange offer and increasing shareholder resistance to the takeover.
  • Regulatory scrutiny intensifies as BBVA-Sabadell would control 39.63% of Catalonian banking credit, raising competition concerns, particularly in SME lending and payment services.
  • The market expects BBVA to raise its offer by 10-20%, but BBVA’s CEO insists there is “no room” for improvement, making shareholder approval uncertain.

EQD | NSE Nifty Bank Index – Implied Volatility Not (Yet) Rich Enough.

By Gaudenz Schneider

  • NSE Nifty Bank Index implied volatility could be seen as rich when compared to its own history and in comparison to realized volatility.
  • Putting implied volatility into context with the NSE Nifty Bank Index 200 day moving average will lead to a different conclusion. Selling volatility might not be the opportunity it seems.
  • This Insight provides a quantitative indication at which level implied volatility can be assessed as rich.

Nikkon Pays 273% Premium for Chuoh Pack (3952 JP) In Takeover

By Travis Lundy

  • Today, Nikkon Holdings (9072 JP) announced it would take over Chuoh Pack Industry (3952 JP) for ¥5,034/share. It closed today at ¥1,349. This is a HUGE win for governance.
  • The 273% premium is not the big win here. For holders it is, of course, but for Japan Inc shareholders everywhere, the win was the auction process. 
  • This could have come out at 100% premium and that might have been OK. As it is, cross-holders and one big holder together get this deal done. Congrats!

EQD | S&P/ASX 200 Option Strategy –  Today’s All-Time-High Calls for Proactive Hedging

By Gaudenz Schneider

  • Today, the S&P/ASX 200 (AS51 INDEX) reached a new all-time high while implied volatility is near record low levels. The combination makes for a good opportunity to hedge.
  • Volatility assessment trough conventional volatility metrics and one new chart not seen anywhere else.
  • An actionable example of a put option hedge is presented, striking a balance between protection and cost.

EQD | Global Option Implied Volatility – Option Opportunities Across the Regions

By Gaudenz Schneider

  • Global option markets present a diverse picture, offering a broad opportunity set.
  • Several markets make for good hedging-candidates after a strong January and amid cheap options.
  • Although several Indian indices show high implied volatility, contextual analysis indicates volatility may be fairly priced relative to their bear trends.

Freebit (3843) Buys Out Minorities in Giga Prize (3830) – Light, But Tough to Block

By Travis Lundy

  • Today, Freebit Co Ltd (3843 JP) announced it would launch a Tender Offer next Monday to buy out minorities in 60.9%-owned Giga Prize (3830 JP)
  • The multiple is not terribly impressive. It could be better. But they only need 5.8% of the 39.1% they do not own to get this over the hump.
  • Synergies are clear. They are expected. They are not priced in the valuation. This is disappointing. Again.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: The Beat Ideas: Blue Jet Healthcare- Rising CDMO Player and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • The Beat Ideas: Blue Jet Healthcare- Rising CDMO Player
  • Intel: A Refreshing Direct Tone from New Management that Doesn’t Deny Issues
  • Top 10 Korean Stock Picks Bi-Weekly (3 February 2025)
  • Lam Research Corporation: Can Its Advanced Packaging & High Bandwidth Memory Expansion Reinforce Footprint In The Semiconductor Landscape?- Major Drivers
  • Boeing’s High-Stakes Production Ramp-Up: Can It Deliver Or Will Chaos Ensue? – Major Drivers
  • Apple Supply Chain Monitor: Latest AAPL Results — Taiwan Suppliers Well Placed for Monday Re-Open
  • KPIT Tech: Strong Q3Y25 Despite Challenging Environment
  • RTX Corporation: Will Its Next-Generation Engine Programs Affirm Leadership Position In The Defense & Aerospace Industry? – Major Drivers
  • The Beat Ideas: Sigachi Industries- High Growth, Revenue Diversification, New Category Launch
  • Avant Corp (3836 JP): 1H FY06/25 flash update


The Beat Ideas: Blue Jet Healthcare- Rising CDMO Player

By Sudarshan Bhandari

  • Blue Jet Healthcare Ltd (BJHC IN) is a science-led pharmaceutical company that has evolved into a strategic partner for the CDMO of advanced Pharmaceutical Intermediates and APIs.
  • Company gave a record breaking Q3FY25 primarily driven by capacity expansion in Contrast media and PI Segment. Strong demand for the cardiovascular product was also witnessed.
  • Company commissioned an additional manufacturing block during Q3 FY25 at Ambernath for manufacturing Advance Contrast Media with investment around Rs. 100Mn.

Intel: A Refreshing Direct Tone from New Management that Doesn’t Deny Issues

By Nicolas Baratte

  • Market looks happy about Intel 4Q result / 1Q guidance. There’s actually a fait bit of poor news for 2025. But the tone / narrative is a lot better.  
  • 2025: Product margins under pressure, Foundry margins better if 18A EUV delivers. Server share loss to be fixed. No GPU. Capex reduced to US$20bn.
  • How much do you pay for “we began the process of resizing our expense structure to support more modest long-term growth”. The stock trades at 13x 2025, 11x 2026 EPS. 

Top 10 Korean Stock Picks Bi-Weekly (3 February 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stocks picks in the Korean stock market for the two weeks starting 3 February.
  • The top 10 stock picks include Orion Holdings, OCI Holdings, Hana Tour Service, Hyundai Motor, KT Corp, Samsung F&M Insurance, Korean Air, Hankook T&T, Young Poong, and NICE Info Service.
  • Our top 10 Korean stock picks from 17 to 31 January are up on average 2.6%, outperforming KOSPI which is down 0.1% in the same period. 

Lam Research Corporation: Can Its Advanced Packaging & High Bandwidth Memory Expansion Reinforce Footprint In The Semiconductor Landscape?- Major Drivers

By Baptista Research

  • Lam Research Corporation reported its earnings for the December 2024 quarter with results largely exceeding guidance midpoints, showcasing strong operational execution and strategic positioning.
  • The company reported a revenue of $4.38 billion, an increase of 5% from the previous quarter.
  • This growth was driven by a balance of increased spending in the DRAM and NAND segments, despite muted NAND spending levels earlier in the year.

Boeing’s High-Stakes Production Ramp-Up: Can It Deliver Or Will Chaos Ensue? – Major Drivers

By Baptista Research

  • The Boeing Company’s recent quarterly earnings call revealed a mixed performance, capturing both progress and ongoing challenges.
  • Key areas of focus included stabilizing production, managing fixed-price development programs, and cultural transformation, against the backdrop of an industry still in recovery.
  • On the commercial aerospace side, Boeing’s production strategy post-IAM strike was highlighted.

Apple Supply Chain Monitor: Latest AAPL Results — Taiwan Suppliers Well Placed for Monday Re-Open

By Vincent Fernando, CFA

  • Apple 1Q25 Results — Overall Price-Supportive for Taiwan Supplier Share Prices When the Taiwan Market Re-Opens Monday
  • Why Zhen Ding Technology Holding (4958 TT) and Kinsus Interconnect Tech (3189 TT) Could Be in a Favorable Position Relative to Apple’s AI Trajectory
  • Increasingly sophisticated Apple products require significantly more complex PCBs & interconnect solutions, especially as advanced packaging has become a key enabler of high-performance computing.

KPIT Tech: Strong Q3Y25 Despite Challenging Environment

By Ankit Agrawal, CFA

  • KPIT Technologies (“KPIT”) reported decent growth despite challenging macroeconomic environment in the automotive OEM segment. Q3FY25 revenue grew 17.4% YoY and 2.0% QoQ in constant currency (CC) terms.
  • Led by improved efficiency and revenue mix, EBITDA margin came in stronger than expected at 21.1%. This led KPIT to raise its FY25 EBITDA guidance to 21%+ from 20.5%+.
  • Deal engagement has been strong. TCV came in at $236mm vs typical run-rate of $150mm+. Deal pipeline is also healthy and the management is expecting substantial closures by H1FY26.

RTX Corporation: Will Its Next-Generation Engine Programs Affirm Leadership Position In The Defense & Aerospace Industry? – Major Drivers

By Baptista Research

  • Raytheon Technologies Corporation (RTX) concluded its fourth quarter of 2024 with robust financial performance, evidenced by significant growth across several key metrics.
  • The company reported adjusted sales of $80.8 billion, marking an 11% organic increase driven by strong performances in commercial original equipment (OE), commercial aftermarket, and defense sales.
  • Adjusted earnings per share (EPS) grew 13% to $5.73, and free cash flow amounted to $4.5 billion.

The Beat Ideas: Sigachi Industries- High Growth, Revenue Diversification, New Category Launch

By Sudarshan Bhandari

  • Sigachi Industries (SIGACHI IN)  has increased MCC capacity to 21,700 MTPA and expects to achieve 80-90% utilization by Q4 FY27 from 50% utilization in Q4FY25.
  • Sigachi is increasing its focus on the API segment, with a target of 20-25% revenue contribution in next 2-3 yrs and further expanding to 35-40% of revenue in 3-5 Yrs.
  • Sigachi is introducing new product lines including pharmaceutical coatings like PureCoat and UltraMod and plans to commercialize Croscarmellose Sodium (CCS) by FY26 to enhance drug stability and bioavailability.

Avant Corp (3836 JP): 1H FY06/25 flash update

By Shared Research

  • Revenue rose to JPY14.0bn (+19.3% YoY), with operating profit margin increasing to 18.1% (+2.0pp YoY).
  • Outsourcing and software businesses drove revenue growth, with order backlog in Q2 FY06/25 at JPY4.8bn (+24.0% YoY).
  • Consolidated employees increased to 1,567, with substantial profit growth in Corporate Management Solutions Business in 1H FY06/25.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: ZKsync & The Elastic Network Endgame and more

By | Crypto, Daily Briefs

In today’s briefing:

  • ZKsync & The Elastic Network Endgame


ZKsync & The Elastic Network Endgame

By Delphi Digital

  • This consulting report explores ZKsync’s transformation from a Layer 2 scaling solution into the Elastic Network, a groundbreaking ecosystem of interoperable ZK Chains positioned to revolutionize institutional blockchain adoption.
  • With Bitcoin ETF inflows exceeding $30B and major players like BlackRock embracing blockchain technology, 2024 has marked unprecedented institutional interest in crypto.
  • However, widespread adoption faces two key challenges: blockchain fragmentation and the inability of public networks to meet institutional requirements for privacy and compliance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars